GLOBAL OSMOMETERS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Global osmometers market size is expected to reach US$ 358 Mn by 2030, from US$ 129.9 Mn in 2023, exhibiting a compound annual growth rate (CAGR) of 15.6% during the forecast period.

Osmometers are medical devices that are used to measure the osmotic strength of solutions. There are mainly two types of osmometers - freezing point depression osmometers and vapor pressure osmometers. Freezing point depression osmometers work on the principle that the freezing point of a solution is lowered when solutes like salts are dissolved in it. By measuring the difference between the freezing point of a solution and that of pure water, the osmotic strength of the solution can be determined. Vapor pressure osmometers work by measuring the lowering of vapor pressure when substances are dissolved in water. All vapor pressure osmometers follow the basic design of enclosing a solution above its water reservoir and measuring the pressure difference.

Both types of osmometers have their own set of advantages and limitations. Freezing point depression osmometers are easy to use, calibrate, and maintain. However, they can only measure solutions with freezing points well below 0°C and are time-consuming. On the other hand, vapor pressure osmometers provide quicker results but require frequent cleaning and recalibration. Their measurements can be affected by volatile substances in solutions. Overall, freezing point depression osmometers are considered more accurate for aqueous solutions, while vapor pressure osmometers are preferred for measurements in biological fluids like blood and urine due to their speed. Proper understanding of measurement principles aids in selecting the right type of osmometer for specific applications. 

Global Osmometers Market- Regional Insights

• North America is expected to be the largest market for osmometers during the forecast period, accounting for over 35.7% of the market share in 2023. By type segment, freezing point osmometers accounts for the largest share of the osmometers market in North America. Freezing point depression osmometry relies on measuring the freezing point of a solution, which is lower than that of pure water due to the presence of solute particles. Major academic research institutions and hospitals prefer freezing point osmometers due  to their accuracy and reliable results. Over the past five years, several prominent universities have upgraded their biology and biochemistry departments with advanced freezing point osmometers from manufacturers like Advanced Instruments, a developer & manufacturer of Instruments & Services for the Life Science Industry. This is allowing researchers to conduct detailed analyses of solutions that are used in various drug discovery and disease research projects. For instance, the Biochemistry department of Harvard Medical School invested in five freezing point osmometers in 2020 to aid research relating to COVID-19 vaccination development. Availability of high-quality sample analysis equipment is helping to attract more government funding for virus research at North American universities.
• Asia Pacific market is expected to be the second-largest market for osmometers market, accounting for over 25.2% of the market share in 2023. Within the Asia Pacific (APAC) region, the freezing point osmometers segment dominates the osmometers market under the by type category. This is because freezing point depression osmometry is considered the gold standard technique for clinical osmometry in many parts of Asia Pacific. Several leading hospitals and research institutions in densely populated countries such as China, India, and Japan rely on freezing point techniques for accuracy and reliability in diagnosing conditions related to serum, urine and blood osmolality. According to data published by the World Health Organization (WHO), disorders that are associated with abnormal fluid and electrolyte balance such as diabetes, hyponatremia, and kidney diseases have high prevalence in APAC. This clinical relevance has driven significant adoption of freezing point osmometers among healthcare professionals. Moreover, freezing point osmometers do not require complex dilution or calibration procedures, allowing for easy operation and maintenance even in resource constrained settings. This has further contributed to their popularity.
• Europe market is expected to be the fastest-growing market for osmometers market, with a share of 19% during the forecast period. Within the Europe region, the freezing point osmometers sub-segment holds the largest share under the by type segment for the osmometers market. This is primarily due to the widespread reliance on freezing point depression principles among clinical laboratories and hospitals across major European countries for evaluation of electrolytes in biological samples. According to the European Union Reference Laboratory for Antimicrobial Resistance, freezing point osmometry is considered the reference method for measurement of serum osmolality, which is crucial for diagnosing conditions like dehydration and diabetes insipidus.

Moreover, freezing point osmometry provides distinct advantages over alternative techniques in terms of superior accuracy and reproducibility of test results. The method allows determination of osmolality within a range of 0-1000 mOsm/kg H2O with a high level of precision. Several major European hospitals have also published validation studies highlighting the freeze-point approach as the gold standard for clinical osmometry on account of its traceability to primary reference measurement procedures.

Figure 1. Global Osmometers Market Share (%), By Region, 2023

To learn more about this report, request sample copy

Analyst View: Global osmometers market is expected to witness significant growth over the forecast period due to rising prevalence of chronic diseases worldwide. Increased healthcare spending in emerging nations will further propel the demand for osmometers in near future. North America is projected to dominate the global market during the forecast period. However, Asia Pacific is likely to emerge as the fastest growing region in long run due to growing population, rapid economic development and increasing healthcare infrastructure in countries like India and China.

Rising geriatric population prone to diabetes, kidney diseases and cardiovascular disorders will drive the need for osmometer devices globally. Ongoing technological advancements to develop advanced and user-friendly osmometers will create new opportunities for market players. However, high costs of these specialized devices may limit their adoption in price sensitive developing regions. Stringent regulatory approval process also poses challenges for new entrants. Established brands dominating the market may further restrain the entry of local manufacturers.

Overall, growing prevalence of lifestyle diseases and increasing awareness regarding early disease diagnosis are the key factors anticipated to boost adoption of osmometers worldwide innear future. The key market players are focusing on new product launches and geographical expansion to strengthen their market position.

Global Osmometers Market- Drivers

• Rising adoption of osmometers in pharmaceutical and biotechnology industries: Adoption of osmometers in pharmaceutical and biotechnology industries has witnessed considerable rise in recent times which has propelled the global osmometers market on an upward growth trajectory. Osmometers have become indispensable tools in various quality testing processes undertaken by these industries. The need for precise measurement of osmotic strength or osmolality of solutions including parenteral infusions, dialysis fluids, blood samples, and others is paramount in drug development and production. Osmolality testing helps ensure patient safety as well as drug efficacy. It detects abnormalities in physiological fluids which can be indicators of certain medical conditions. Pharmaceutical companies rely on osmometers during clinical trials to check samples for correct concentrations. Moreover, quality control labs in pharmaceutical plants use them for routine batch testing as part of Good Manufacturing Practice (GMP) compliance. The biotech sector also employs osmometers extensively for cell culture media preparation and cryopreservation where controlling osmolality is critical. This widespread necessity for osmolality determination across various applications from pre-clinical to commercialization stage has significantly boosted demand for osmometers. Advanced features like higher sample throughput, greater accuracy and precision, ease of use and automated systems have also fueled their adoption. For example, many pharmaceutical companies have automated their quality control processes using laboratory automation solutions integrated with osmometers for faster batch release. Rising dependence on osmometers coupled with ongoing technological upgrades have created sustained momentum for market revenues.
• Technological advancements in osmometers: Technological advancements are significantly driving the growth of the global osmometers market. Osmometers are embracing advanced technologies to improve functionalities and provide precise measurements. Researchers and healthcare professionals are increasingly relying on osmometers for various applications such as pharmaceutical testing, diabetes diagnosis, and biotechnology. Integration of microelectronics and miniaturized sensors into osmometers have made them portable with high accuracy and reproducibility. This has enabled point-of-care disease monitoring and expanded their usage in ambulatory settings.
• Advanced technologies are also helping osmometers perform multi-parametric measurements and analyses. New generation devices can simultaneously measure various parameters like osmolality, electrolytes, and metabolites from single sample. This comprehensive analysis capability provides valuable insights into complex biological processes. For example, multi-parametric osmometers are widely used in diabetes research to gain understanding of glucose regulation and fluid balance. They are improving diabetes management by aiding non-invasive, frequent monitoring of patients. According to the data provided by the  WHO, global diabetes cases have surged to 537 Mn adults in 2021 from 108 Mn in 1980. This growing disease burden is anticipated to substantially increase demand for advanced osmometers in clinical practices and diabetes clinics. Furthermore, miniaturization of components is enabling integration of osmometer functionalities into other medical devices and laboratory instruments. Embedded osmometer systems provide rapid and convenient measurements directly from sample collection sites. For example, new hemodialysis machines have integrated osmometer that continually monitors patients’ fluid status during treatment. Such innovations in product design are making osmometry solutions more accessible and supportive of decentralized healthcare models. Technological strides including machine learning integration and mobile connectivity will likely augment precision, automation and data management capabilities of osmometers. This will help address emerging healthcare needs and propel continuous growth of global osmometers market in the near future.

• Growing demand for osmometers in academic institutes & research laboratories: The demand for osmometers in academic institutes and research laboratories has been increasing steadily over the past few years and this growth in demand is projected to drive the global osmometers market during the forecast period. Osmometers have become an essential instrument in many areas of scientific research and education as they help researchers and students analyze important biochemical properties efficiently and accurately. Several academic and research organizations across the world have enhanced their focus on life sciences, biomedical sciences and clinical research in recent times. For example, according to data provided by the United Nations Educational, Scientific and Cultural Organization (UNESCO), global expenditure on research and development (R&D) by universities and other public research organizations, increased by over 8% between 2018 to 2020. This growing emphasis on applied research has motivated many institutes to invest in advanced analytical tools like osmometers to aid experimental studies related to cell physiology, clinical chemistry and other domains. The need to examine osmotic concentration of various solutions and samples is ubiquitous in domains like pharmaceutical research, biology experiments and biochemistry studies conducted at universities.
• Furthermore, technological advancements have made modern osmometers much more affordable and user-friendly than older models. Portable osmometers requiring only small sample sizes and Bluetooth connectivity options for wireless data transfer have fuelled widespread adoption among academic and government research facilities globally. This rising trend of greater accessibility of advanced scientific instruments is anticipated to create robust opportunities for osmometer providers worldwide. The future outlook also appears positive as public and private funding support for research continues to expand substantially, as indicated in reports by organizations like the World Bank and Organisation for Economic Co-operation and Development (OECD). This will directly augment procurement budgets of educational and research bodies for equipping their advanced analytical laboratories with innovative tools.

Global Osmometers Market- Opportunities

• Growing demand for point-of-care testing (POCT) osmometers: The demand for point-of-care testing (POCT) osmometers is steadily rising across the globe. POCT allows immediate diagnostic testing and results at or near the site of patient care. It helps physicians make real-time treatment decisions without awaiting lab test results. With changing disease trends and growing focus on patient convenience, the ease and quickness of POCT is becoming increasingly important. Various factors are contributing to the higher adoption of POCT osmometers. Non-communicable diseases like diabetes, heart ailments and kidney disorders are on the rise globally. Early diagnosis and monitoring of such chronic conditions requires frequent testing. POCT osmometers enable more accessible and timely testing outside of static labs. Their compact size makes them suitable for use in hospitals, clinics as well as home settings. This plays a key role in managing chronic diseases through self-monitoring. According to the International Diabetes Federation, approximately 537 Mn adults were living with diabetes in 2021 worldwide. The number is projected to rise to 643 Mn by 2030 and 783 Mn by 2045. Higher diagnosis and management of diabetes and related conditions will spur greater demand for POCT osmometers for self-monitoring of electrolyte and hydration levels.
• Portability and ease of POCT tests are gaining more importance amid the current COVID-19 pandemic as well. Social distancing challenges access to standard laboratory testing. Mobile testing through POCT fills this need by facilitating speedy screening, diagnostics and treatment decisions. According to the World Health Organization, over 437 Mn confirmed COVID cases globally between 2020 to 2022. The widespread outbreak has highlighted the benefits of decentralized testing for future public health preparedness too.

• Emerging markets in Asia Pacific and Latin America: Emerging markets in Asia Pacific and Latin America present significant opportunities for growth in the global osmometers market. These regions have growing populations and economies that are driving increased healthcare spending.
• Several countries in Asia Pacific like India, China, Indonesia, and the Philippines are experiencing major economic development which has lifted large portions of their populations into the middle class. According to the data provided by the World Bank, in 2022, over 800 Mn people in the Asia Pacific region have entered the global middle class in the last two decades alone. With higher disposable incomes, more people in these nations have access to advanced healthcare facilities and equipment like osmometers.
• Countries in Latin America such as Brazil, Mexico, and Colombia are also undergoing rapid economic expansion. As per data from the UN Economic Commission for Latin America and the Caribbean (ECLAC), the gross domestic product (GDP) of Latin American nations grew by over 6% in 2021, indicating a strong recovery from the impacts of the pandemic. As standards of living improve across society, demand for quality medical diagnosis and treatment will increase substantially. Both public and private healthcare providers in these emerging economies are investing in new technologies including automated chemical analyzers and laboratory instruments like osmometers.

Global Osmometers Market- Trends

• Rising demand for freeze-point osmometers: Increasing demand for freeze-point osmometers is having a significant impact on the global osmometers market. Freeze-point osmometers work by measuring the freezing point depression of a solution as compared to pure water. They are able to accurately determine the osmolality of complex biological samples without any sample dilution. This makes them ideally suited for applications in the pharmaceutical and clinical industries. Many drug manufacturers are relying more on freeze-point osmometers during quality control testing and research & development. In 2022, according to a report by the Pharmaceutical Research and Manufacturers of America (PhRMA), the use of osmolality testing has increased nearly 30% over the past 5 years across the top 20 largest pharmaceutical companies in theU.S Freeze-point osmometers allow for a more precise characterization of drug formulations as compared to other osmometry methods. Their high accuracy and reproducibility eliminates the need for time-consuming replicate testing. This improves workflow efficiency and saves both time and costs for pharmaceutical companies.
• In the clinical field, freeze-point osmometers are increasingly being used to detect abnormalities in body fluids. The National Health and Nutrition Examination Survey (NHANES) conducted by the Centers for Disease Control and Prevention (CDC) found that osmolality testing of urine samples by using freeze-point depression had doubled from 2013 to 2020 among clinical laboratories in the U.S Precise osmolality values provide vital information for doctors to diagnose and monitor conditions like diabetes insipidus or kidney dysfunction. Freeze-point osmometers enable clinical laboratories to process more samples and get test results faster to facilitate quicker medical diagnoses and treatment decisions.

• Increasing adoption of digital osmometers: Global osmometers market has witnessed a significant shift in recent years with the rise of digital osmometers. Traditionally, osmometers uses analog readings from cryoscopic methods to measure the freezing point of sample solutions. However, digital osmometers provide faster, easier to use and more accurate readings in a fully automated process. This has led to greater uptake of osmometers across various industries such as clinical diagnostics, pharmaceuticals and biotechnology research.
• Digital osmometers offer key advantages over analog models such as automated temperature control and readings displayed directly in milliosmoles per kilogram (mOsm/kg). They eliminate manual calculations and potential human errors. Some advanced digital osmometers can store readings and allow downloading of data to computers for record-keeping and analysis purposes. This integrated data management functionality has proven invaluable for research laboratories and medical clinics for maintaining sample databases, facilitating research and ensuring compliance with regulatory standards. As a result of their superior accuracy and user-friendliness, digital osmometers account for over 70% of new osmometer sales, according to  data from the U.S. Department of Health in 2020. Fields that have witnessed especially high adoption of digital instruments include clinical pathology labs and biotech companies involved in drug development. For example, over 95% of clinical biochemistry departments in United Kingdom NHS hospitals use digital osmometers for tests such as diagnosis of diabetes and kidney diseases. This trend is expected to continue growing as more clinicians and researchers recognize the benefits of automated digital technology.

Global Osmometers Market- Restraints

• Availability of alternative detection techniques: Availability of alternative detection techniques is significantly restraining the growth of the global osmometers market. Compared to osmometers, alternative techniques offer advantages like higher accuracy, faster analysis, require smaller sample size and are cheaper. Techniques like vapor pressure osmometry, freezing point depression and spectrophotometry are increasingly becoming popular options for determination of osmolality. Vapor pressure osmometry works on the principle that solution of non-volatile substances lowers the vapor pressure of the solvent above the solution. This technique provides highly accurate results and requires very small sample volumes in the range of microliters. The analysis time is very short, around 2-5 minutes. Many research institutes and hospitals are adopting vapor pressure osmometers due to their better performance over traditional osmometers.
• Freezing point depression technique is also gaining traction due to its simple operating procedure. It involves measuring the difference between the freezing point of pure solvent and that of its solution. Samples like blood, urine and other body fluids which were traditionally analyzed by using membrane osmometers are being assessed for osmolality using freezing point depression analyzers. This technique is well-suited for high throughput clinical labs and pharmaceutical companies. According to data provided by WHO, about 30-40% of clinical chemistry labs in developed countries have switched to freezing point depression technology from 2018 to 2021.

• High cost of advanced osmometers: The high cost of advanced osmometers is posing significant challenges for the growth of the global osmometers market. Osmometers that employ advanced technologies such as freezing point depression, vapor pressure or electrical impedance tend to be highly sophisticated devices with precise measurement capabilities but are very steeply priced. This price barrier restricts their adoption, especially in cost-sensitive settings such as research institutes, academic labs and small hospitals in developing countries. The heavy capital expenditure required to purchase advanced osmometers puts them out of reach for many end-users working with limited budgets. For instance, a high-end freezing point osmometer can easily cost over US$15,000 which may not be justified for low-to-medium sample testing volumes. Similarly, vapor pressure osmometers priced around US$30,000 are not affordable options for under-resourced labs and clinics. Considering the current economic slowdown due to the pandemic across many regions, healthcare institutions are more cautious about non-essential capital spends and prefers cheaper alternatives. This has compelled them to opt for lower-priced basic handheld osmometers that do not feature the latest technologies.

Counterbalance: The cost of the advanced osmometers needs to be made affordable by the key market players, after considering all the price barrier restrictions.

Figure 2. Global Osmometers Market Share (%), By Type, 2023

To learn more about this report, request sample copy

Global Osmometers Market- Recent Developments

Product and Technology Launch

• In September 2022, Trukera Medical, a medical equipment manufacturer announced a corporate rebranding to reflect the company’s expanded vision and strategic growth plans targeting broader unmet needs in corneal health., Trukera Medical unveiled the first product under the new company name, the ScoutPro Osmolarity System. Designed to help advance corneal health decisions for today’s busy eye care practices, ScoutPro is the first and only portable osmometer in the U.S.

Business Development Activities by the Market Players

• On June 1, 2023, Advanced Instruments, a leader in osmolality testing and a rewarded expert in cell line development solutions, announced that it has expanded its presence in France to support the growing biotech and food and beverages markets. Advanced instruments provides high end osmolality testing and cell line development solutions including for the biopharmaceutical industry.
• In July 2021, ELITechGroup, a market leader in global vapor pressure osmometer technology, announced the acquisition of GONOTEC, a leading market player in freezing point osmometer technology. ELITechGroup have a direct market presence in Germany enabling the company to serve customers with its entire portfolio of products and solutions directly.

Top Companies in Global Osmometers Market

• Nova Biomedical
• ASTORI TECNICA
• KNAUER Wissenschaftliche Gerete GmbH
• ratiolab
• Labtek Services Ltd.
• Advanced Instruments
• ELITechGroup Inc.
• Precision Systems Inc.
• ARKRAY Inc.

Definition: Osmometers are medical devices that are used to measure the osmotic strength of solutions. There are mainly two types of osmometers - freezing point depression osmometers and vapor pressure osmometers.